Tjan-Heijnen VC - Search Results

1

Is the sentinel lymph node pathology protocol in breast cancer patients associated with the risk of regional recurrence?

Bolster MJ, Pepels MJ, Wauters CA, Schapers RF, Meijer JW, Strobbe LJ, van Berlo CL, Klinkenbijl JH, Wobbes T, Voogd AC, Bult P, Tjan-Heijnen VC. Bolster MJ, et al. Eur J Surg Oncol. 2013 May;39(5):437-41. doi: 10.1016/j.ejso.2013.02.013. Epub 2013 Feb 23. Eur J Surg Oncol. 2013. PMID: 23462244 Free article.

2

Treatment in germ cell tumours: state of the art.

Tjan-Heijnen VC, Oosterhof GO, de Wit R, De Mulder PH. Tjan-Heijnen VC, et al. Eur J Surg Oncol. 1997 Apr;23(2):110-7. doi: 10.1016/s0748-7983(97)80002-9. Eur J Surg Oncol. 1997. PMID: 9158183 Review.

3

Micro-metastases in axillary lymph nodes: an increasing classification and treatment dilemma in breast cancer due to the introduction of the sentinel lymph node procedure.

Tjan-Heijnen VC, Buit P, de Widt-Evert LM, Ruers TJ, Beex LV. Tjan-Heijnen VC, et al. Breast Cancer Res Treat. 2001 Nov;70(2):81-8. doi: 10.1023/a:1012938825396. Breast Cancer Res Treat. 2001. PMID: 11768607 Review.

4

The prognostic value of vascular endothelial growth factor in 574 node-negative breast cancer patients who did not receive adjuvant systemic therapy.

Manders P, Beex LV, Tjan-Heijnen VC, Geurts-Moespot J, Van Tienoven TH, Foekens JA, Sweep CG. Manders P, et al. Br J Cancer. 2002 Sep 23;87(7):772-8. doi: 10.1038/sj.bjc.6600555. Br J Cancer. 2002. PMID: 12232762 Free PMC article.

5

The prognostic value of the mitotic activity index in patients with primary breast cancer who were not treated with adjuvant systemic therapy.

Manders P, Bult P, Sweep CG, Tjan-Heijnen VC, Beex LV. Manders P, et al. Breast Cancer Res Treat. 2003 Jan;77(1):77-84. doi: 10.1023/a:1021138801890. Breast Cancer Res Treat. 2003. PMID: 12602906

6

Stage migration in breast cancer: surgical decisions concerning isolated tumour cells and micro-metastases in the sentinel lymph node.

de Widt-Levert L, Tjan-Heijnen V, Bult P, Ruers T, Wobbes T. de Widt-Levert L, et al. Eur J Surg Oncol. 2003 Apr;29(3):216-20. doi: 10.1053/ejso.2002.1401. Eur J Surg Oncol. 2003. PMID: 12657229

7

Vascular endothelial growth factor independently predicts the efficacy of postoperative radiotherapy in node-negative breast cancer patients.

Manders P, Sweep FC, Tjan-Heijnen VC, Geurts-Moespot A, van Tienoven DT, Foekens JA, Span PN, Bussink J, Beex LV. Manders P, et al. Clin Cancer Res. 2003 Dec 15;9(17):6363-70. Clin Cancer Res. 2003. PMID: 14695136

8

Vascular endothelial growth factor levels do not predict efficacy of systemic adjuvant treatment as assessed in 1127 breast cancer patients.

Manders P, Beex LV, Tjan-Heijnen VC, Span PN, Sweep CG. Manders P, et al. Int J Oncol. 2004 Aug;25(2):511-7. doi: 10.3892/ijo.25.2.511. Int J Oncol. 2004. PMID: 15254751

9

Complex of urokinase-type plasminogen activator with its type 1 inhibitor predicts poor outcome in 576 patients with lymph node-negative breast carcinoma.

Manders P, Tjan-Heijnen VC, Span PN, Grebenchtchikov N, Geurts-Moespot A, van Tienoven DT, Beex LV, Sweep FC. Manders P, et al. Cancer. 2004 Aug 1;101(3):486-94. doi: 10.1002/cncr.20374. Cancer. 2004. PMID: 15274061 Free article.

10

[Detailed pathological examination of the sentinel lymph nodes in order to detect micrometastases: no clinical relevance in patients with breast cancer].

Tjan-Heijnen VC, Bult P, Bolster MJ, Peer PG, Wobbes T. Tjan-Heijnen VC, et al. Ned Tijdschr Geneeskd. 2005 Feb 26;149(9):494; author reply 494-5. Ned Tijdschr Geneeskd. 2005. PMID: 15771346 Dutch. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

310 results

Search Page

Filters